World Pharma News

12

Feb2019
New York-based Progenics last year picked up an FDA approval for its orphan radiotherapeutic. Now it has picked ... Read More

12

Feb2019
Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for use on ... Read More

12

Feb2019
Reeves is an associate professor in the School of Public Health and Health Sciences at the University of ... Read More

12

Feb2019
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2019-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, ... Read More